New Zealand, which carries one of the world's heaviest cancer burdens, has long separated the work of treating the disease from the work of understanding it. The University of Auckland is now opening a Department of Cancer Sciences designed to close that gap — placing clinicians, laboratory scientists, and clinical trial researchers under a single roof on the evidence that proximity between care and inquiry measurably improves patient outcomes. It is less a technological leap than an architectural and organisational reckoning: an acknowledgment that the country has fallen behind a global stand
Auckland University launches integrated cancer centre combining research and clinical care
New Zealand has one of the highest cancer incidence rates globally, with the new centre intended to improve outcomes for cancer patients through integrated research and clinical care.
They have some hope that they can change the future, and the patients feel that.
Mark
Why does it matter that researchers and clinicians are in the same building? Couldn't they just email each other?
Mimi
They could, but something changes when you're in the same space. A clinician sees a patient with an unusual response to treatment. They walk down the hall and find the scientist. They talk in real time. The scientist goes back to the lab with a real problem to solve, not an abstract question.
Mark
So it's about proximity and spontaneity.
Mimi
Exactly. And it's about culture. When researchers see patients, they understand the stakes. When clinicians see the lab, they understand what's possible. You can't fake that through email.
Mark
New Zealand ranks second for cancer incidence globally. Why hasn't this happened before?
Mimi
Partly inertia. Hospitals and universities have operated separately for a long time. Partly resources. A comprehensive cancer centre requires sustained funding and coordination. But also, I think, because no one made it a priority until now.
Mark
What happens next?
Mimi
They're planning to integrate this with Auckland Hospital's cancer building replacement. If that works, you have a model that could change how cancer care happens in New Zealand.
O Pulso
- New Zealand ranks second in the world for cancer incidence, yet has none of the roughly thirty integrated comprehensive cancer centres that exist globally — a structural gap with real consequences for patients.
- The founding director, drawing on time spent at Yale and other major overseas centres, argues that the simple act of putting oncologists in the same hallway as lab scientists accelerates problem-solving in ways that isolated facilities cannot replicate.
- Between 2000 and 2020, New Zealand improved cancer cure rates by ten percent — gains attributed to new research and better care delivery — and the new centre is designed to compound that momentum by fusing both in one place.
- The centre is being planned in deliberate alignment with Auckland Hospital's aging cancer building replacement, creating a rare window to embed research infrastructure into new construction rather than retrofit it later.
- The vision is explicitly scaled and grounded — smaller than billion-dollar proposals floated publicly, focused on genuine collaboration over parallel operation, and oriented toward reducing the travel burden on patients across the region.
New Zealand, which carries one of the world's heaviest cancer burdens, has long separated the work of treating the disease from the work of understanding it. The University of Auckland is now opening a Department of Cancer Sciences designed to close that gap — placing clinicians, laboratory scientists, and clinical trial researchers under a single roof on the evidence that proximity between care and inquiry measurably improves patient outcomes. It is less a technological leap than an architectural and organisational reckoning: an acknowledgment that the country has fallen behind a global standard, and a deliberate effort to catch up.
The University of Auckland is launching a new Department of Cancer Sciences built on a deceptively simple premise: patients fare better when the people treating them work alongside the people studying the disease. Most cancer facilities in New Zealand keep those two functions apart. This centre will not.
Founding director Lawrence, who has observed major cancer centres in the United States and elsewhere, points to a global model New Zealand has never adopted. Around thirty comprehensive cancer centres worldwide co-locate clinical care, laboratory science, drug discovery, and clinical trials. The logic is practical — when a clinician hits a problem they cannot solve alone, the scientist is down the hall. Conversations happen. Research responds. "They have some hope that they can change the future, and the patients feel that," Lawrence said. New Zealand lifted its cancer cure rates by ten percent between 2000 and 2020 largely through new knowledge and improved care delivery; an integrated centre could accelerate that further.
The stakes are significant. New Zealand ranks second globally for cancer incidence, behind only Australia. The university's plan is to weave the new centre into Auckland Hospital's cancer building, which is aging and already slated for replacement by Health New Zealand. That convergence of timing is deliberate — an opportunity to design research into the structure from the outset, rather than as an afterthought. Lawrence envisions it as a regional mothership, easing the burden on patients who currently make repeated trips into central Auckland for care.
The ambition is real but measured. Where others have proposed billion-dollar international cancer hospitals, Lawrence's focus is narrower and more immediate: organisational architecture over spectacle, collaboration over parallel operation. What the centre offers is not a new drug or a breakthrough device, but the recognition that in cancer care, proximity between inquiry and treatment is itself a form of medicine.
The University of Auckland is opening a new Department of Cancer Sciences, and its founding director has a straightforward theory about why it matters: patients get better care when their doctors work in the same building as the researchers trying to solve cancer.
The centre will do something most cancer facilities in New Zealand do not—treat patients and conduct research under one roof. The university will fund the research side. The clinical care will happen alongside it, in shared space, with the same hallways connecting oncologists to laboratory scientists to drug developers to the people running clinical trials.
Director Lawrence has spent time at Yale and other major cancer centres overseas, and he noticed something about how New Zealand operates. "We need to bring population health, lab scientists, drug discovery, clinical trials all together," he said. "And that's what other centres can do overseas." There are roughly thirty comprehensive cancer centres worldwide that work this way. New Zealand has not been one of them.
The reasoning is not mystical. When a clinician finishes seeing a patient and encounters a problem they cannot solve alone, the scientist is there. They talk. The scientist goes back to the lab. Problems get solved faster. Patients feel it. "They have some hope that they can change the future, and the patients feel that," Lawrence said. Between 2000 and 2020, New Zealand increased cancer cure rates by ten percent—a gain he attributes mostly to new knowledge from research and improvements in how care is delivered. A centre that fuses both could accelerate that.
New Zealand ranks second globally for cancer incidence, behind only Australia. The burden is real and growing. The university's plan is to integrate this new centre with Auckland Hospital's existing cancer building, which is aging and scheduled for replacement. Health New Zealand is already planning that renovation. The timing creates an opportunity to build research into the new structure rather than treating it as an afterthought. Lawrence calls it a "mothership"—a regional hub that would reduce the burden on patients who currently have to drive into central Auckland repeatedly for care.
The scope is ambitious but not unlimited. Broadcaster Paul Henry recently proposed a "world-class cancer hospital" that would serve both New Zealanders and international patients, estimating the cost in the billions. Lawrence's vision is smaller and more focused. "It will be a lot less than that," he said. The university is in the planning phase now, working through the logistics of bringing health professionals, researchers, and patients into genuine collaboration rather than parallel operation.
What Lawrence is describing is not new technology or a breakthrough drug. It is architecture—physical and organizational. It is the recognition that cancer care improves when the people who treat it sit next to the people who study it, when a clinician's question becomes a researcher's next project, when hope and evidence occupy the same space. New Zealand has fallen behind on this. The new centre is an attempt to catch up.
Citações Notáveis
We need to bring population health, lab scientists, drug discovery, clinical trials all together. And that's what other centres can do overseas.— Lawrence, founding director of the Department of Cancer Sciences
You can't beat being in the same place, bumping into the same people when you come out of clinic and you've got a problem that you can't solve, and the scientist is there.— Lawrence
Quer a matéria completa?
Leia o original em The New Zealand Herald ↗
Health & Medicine